Skip to main content

Former Bristol-Myers Squibb executive named CEO of immunotherapy company

The new CEO was the company's interim CEO for the past four months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.